Modelling of Continuous L-Malic Acid Production by Porcine Heart Fumarase and Fumarase in Yeast Cells by A. Vrsalović Presečki et al.
Modelling of Continuous L-Malic Acid Production by Porcine Heart Fumarase
and Fumarase in Yeast Cells
A. Vrsaloviæ Preseèki,* B. Zeliæ, and Ð. Vasiæ-Raèki
University of Zagreb, Faculty of Chemical Engineering and Technology,
Department for Reaction Engineering and Catalysis,
Savska c. 16, 10 000 Zagreb, Croatia
Dedicated to the memory of Professor Dr. Valentin Koloini
Continuous production of L-malic acid will be presented in this paper. The fumarase
isolated from porcine heart, fumarase in the permeabilized non-growing cells of baker’s
yeast and Saccharomyces bayanus (UVAFERM BC) were used as biocatalysts. In the pro-
duction of L-malic acid with fumarase isolated from porcine hearts, there was no enzyme de-
activation for a period of two days. At the average residence time of 4 hours, the conversion
of about 80 % was achieved. Inactivation of the enzyme was observed using permeabilized
cells. This inactivation is described as a reversible process. Conversion of about 50 % was
achieved with the remaining enzyme activity. A mathematical model that describes the pro-
duction of L-malic acid, which contains the enzyme inactivation rate, was developed. Based
on simulations, the used biocatalysts were compared. The results show that in the continuous
production of L-malic acid, one milligram of purified enzyme corresponds to 68 g (wet
weight) cells of Saccharomyces bayanus or 120 g (wet weight) cells of baker’s yeast.
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Introduction
Malic acid has a wide range of applications and
is a “bulk” chemical, which has estimated con-
sumption of 40,000 t annually. It is used in the
food, animal food, pharmaceutical, cosmetic and
building industry.1 This is the second largest
acidulant used in the food industry after citric acid,
and holds about 10 % of the market.2
L-Malic acid can be prepared by extraction
from natural fruit juices, but this process is not eco-
nomical, because fruit juices contain less than 1 %
of L-malic acid.1 Commercial chemical synthesis
based on the hydration of fumaric or maleic acid,
carried out at high pressure and high temperature
gives racemic mixture of D- and L-malic acid.3 In-
dustrially, L-isomer of malic acid is produced by an
enzymatic process that transforms the fumaric acid
to L-malic acid and this biotransformation is cata-
lyzed by enzyme fumarase.4–5
Fumarase enzyme as a biocatalyst can be used
as whole cells1,5,6 or as a purified enzyme.7 Using
whole cells, expensive and time-consuming enzyme
purification operations are avoided. In this way, the
enzyme is in its natural environment and is pro-
tected from inactivation during subsequent use in
the continuous system.8 Major limitations that need
to be addressed when using such cells are the diffu-
sion of substrates and products through the cell wall
and side reactions due to the presence of other en-
zymes in the cell. These problems can be overcome
by using permeabilized cells as a source of en-
zymes. Permeabilization of cells removes barriers
to free diffusion of the substrates/products across
the cell membrane and permeabilized cells can re-
lease most of the low molecular weight cofactors,
etc., which reduces the side reactions.9 This fact is
very important for L-malic production with whole
cells, because both side reactions with which malic
acid and fumaric acid are involved in the Krebs cy-
cle for production of oxalic acid or succinic acid,
require the coenzymes. Several commercial strains
of yeast were tested as a source of fumarase in our
previous work.10 To achieve higher activity of the
cells, cell permeabilization with CTAB (hexadecyl-
trimethylammonium bromide) was performed be-
fore the cells were used in the process. Because of
this treatment, production of by-products such
as succinic acid was eliminated. For further investi-
gation, two yeasts were selected: wine yeast
Saccharomyces bayanus (UVAFERM BC), whose
cells showed the highest activity of fumarase and
baker’s yeast. The baker’s yeast was selected due to
its availability and low price. For fumarase in both
yeast cells and isolated fumarase from porcine
heart, kinetic parameters were estimated and were
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further confirmed in experiments that were carried
out in the batch reactor.10,11
The aim of this study was to investigate contin-
uous processes and to develop valid mathematical
models thereof. These models should allow predic-
tion of the production of L-malic acid in different
operating conditions, and could help evaluate the
advantages or disadvantages of the process.12,13 Re-
actor with ultrafiltration or microfiltration mem-
brane at the exit was used to design an efficient pro-
duction process in a continuous mode. Membrane
serves to keep the large components such as cells
and enzymes within the reactor, while allowing
small molecules to pass through it.14,15
Experimental part
Materials and microorganism
Fumaric acid, L-malic acid, hexadecyltrimethyl-
ammonium bromide (CTAB) and KH2PO4 were pur-
chased from Fluka Chemie (Switzerland) and per-
chloric acid was from Merck (Germany). Na2HPO4
and K2HPO4 were purchased from Kemika (Croatia).
Fumarase from porcine heart (E.C. 4.2.1.2) was from
SIGMA-ALDRICH (Germany). Wine yeast
(Saccharomyces bayanus – UVAFERM BC) was from
Danstar ferment AG (Denmark) and fresh baker’s
yeast was purchased from KVASAC d.o.o (Croatia).
Continuous production of L-malic acid catalyzed
by fumarase purified from porcine heart
Continuous production of L-malic acid cata-
lyzed by the purified enzyme was carried out in en-
zyme membrane reactor (EMR – Figure 1A).12,15,16
Reactor volume was 10 cm3. The reactor was
kept at constant temperature of 30 °C. Reaction was
initiated with the addition of fumarase by injection
through the septum. Polymer membrane (Amicon
XM50, Milipore, USA) was used to keep the en-
zyme in the reactor. Fumarase concentrations were
4.48, 9.80 and 12.82 mg dm–3, average residence
times were set at 53 and 240 min with a piston
pump (M160, RCT, Germany) and fumaric acid
concentration in the feed was 63 mmol dm–3.
Continuous production of L-malic acid
with permeabilized yeast cells
For continuous production of L-malic acid by
yeast cells, two types of yeast were used: a wine
yeast – Saccharomyces bayanus and baker’s yeast –
Saccharomyces sp. Cells were permeabilized ac-
cording to the procedure described elsewhere10,11
and were used for the biotransformation of fumaric
to L-malic acid as a non-growing cell.
Experiments were carried out in a 2 dm3
bioreactor (Biostat MD, B. Braun, Germany, Figure
1B). Volume of reaction mixture was one dm3. It
was maintained constant by regulation of outlet
flow, while inlet flow was kept constant. The solu-
tion was stirred at 200 min–1 and kept at a constant
temperature of 30 °C. Ultrafiltration unit (UF-30-E-3,
A = 0.07 m2, cut off = 30 kDa, Sempas Membran-
technik GmbH, Germany) was used to keep the
permeabilized yeast cells inside the reactor. For
the continuous production by baker’s yeast cells,
50 gww dm–3 of permeabilized cells were used. Aver-
age residence time was 914 min and fumaric acid
concentration in the feed was 220 mmol dm–3. In
the experiment, catalyzed by fumarase in the cells
of a wine yeast Saccharomyces bayanus, permeabi-
lized cell concentration was 36 g (wet weight) dm–3.
Average residence time was 887 min and the con-
centration of fumarate in the inlet flow was
200 mmol dm–3. Fumaric acid was dissolved in
a phosphate buffer (0.1 mol dm–3), and pH was set
to 7.
HPLC analysis
The fumaric and L-malic acid were analyzed
with HPLC (LC-20 AT, Shimadzu, Japan) using the
reverse phase C18 column (LiChrosorb® RP-18,
5 m, 125 x 4 mm, Merck, Germany) and the UV
detector at 210 nm. Mobile phase was water (pH
2.10–2.15 adjusted with perchloric acid) at a flow
rate of 0.7 cm3 min–1. The analysis was carried out
at a temperature 30 °C.
Mathematical model and data processing
A mathematical model for continuous L-malic
acid production includes kinetic and reactor model.
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F i g . 1 – Experimental set-up for the continuous L-malic
acid production by: (A) isolated fumarase; (B)
permeabilized yeast cells
The kinetic experiments for the reaction of L-malic
acid production from fumaric acid catalyzed by the
isolated fumarase and the fumarase from whole
yeast cells were reported previously.10,11
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Since the reaction is reversible (eq. 1) the ki-
netic model consisted of the equation for the
fumaric acid hydration (reaction 1), and the equa-
tion for the reverse reaction of L-malic acid dehy-
dration (reaction 2). For purified fumarase from
porcine heart, kinetics of both reactions were de-
scribed by Michaelis-Menten equation with com-
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Biocatalyst inactivation was observed during
experiments in which yeast cell were used. Inacti-
vation mechanism is described by eq. 4, which in-
cludes active and inactive form of enzyme in cell of
yeast that are in balance with each other.17,18
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In the case of permeabilized yeast cells, kinet-
ics of fumaric acid hydration was also described
with the Michaelis-Menten equation with competi-
tive product inhibition (eq. 5), while the reverse re-
action kinetics of L-malic acid dehydration is de-































Kinetic parameters were estimated previously
by non-linear regression analysis,10,11 and are given
in Table 1.
The balance equations for the yeast with active,
as well as for the yeast with inactive enzyme are
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The reactor model is based on mass balance
equations (eqs. 9–10) for an ideal continuous stirred
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T a b l e 1 – Kinetic parameters of isolated fumarase and fumarase in permeabilized yeast cells estimated previously
Parameters Fumarase isolated from porcine heart*
Fumarase in permeabilized yeast cells
Saccharomyces bayanus** baker’s yeast Saccharomyces sp.*
Vm1/
U mg–1 607.214 ± 17.220
U g–1 (wet weight) 264.995 ± 8.183 94.057 ± 1.215
Km1 mmol dm
–3 3.999 ± 0.364 18.812 ± 1.618 4.379 ± 0.317
Vm2/
U mg–1 179.456 ± 2.607
U g–1 (wet weight) 84.075 ± 0.986 26.379 ± 0.724
Km2/mmol dm
–3 4.286 ± 0.199 19.360 ± 0.683 13.912 ± 1.297
K i
fumaric acid /mmol dm–3 0.279 ± 0.031 33.078 ± 2.870 5.217 ± 0.429
K i
malic acid /mmol dm–3 1.807 ± 0.093 – –
* Preseèki, A. V., Zeliæ, B., Vasiæ-Raèki, Ð., Enzym. Microb. Technol. 41 (2007) 605.
** Preseèki, A. V., Vasiæ-Raèki, Ð., Biotech. Lett. 27 (2005) 1835.
Constants in eqs. 7–8 (inactivation constant, kd
and the activation constant, ka) were estimated by
non-linear regression analysis using the data of ex-
periments in the reactor. Simplex method and the
method of least squares implemented in commercial
software (SCIENTIST) were used20 to estimate val-
ues of parameters. Parameters values were calcu-
lated by fitting a mathematical model to experimen-
tal data. Calculated data were compared with exper-
imental data, recalculated in the optimization rou-
tine and were evaluated again until the minimum
error between the experimental and calculated value
was realized. The optimal parameters were used to
simulate the model equations. The Episode algo-
rithm20 for stiff systems of differential equations,
also included in the SCIENTIST software, was used
for the simulation of eqs. 7–10.
Results and discussion
Continuous L-malic acid production catalyzed
by isolated fumarase
Parameters of the kinetic model for isolated
fumarase (eqs. 2–3) were estimated by independent
measurements in our previous work11 (Table 1).
Mathematical model (eqs. 2–3, 9–10) was validated
in continuous enzyme membrane reactor for the
L-malic acid production for three enzyme concen-
trations and two residence times (Fig. 2).
It can be seen that the mathematical model
agrees with experimental data in all conditions (Fig.
2). Fumaric acid conversion was changed, depend-
ing on the residence time and enzyme concentration
(Table 2). At the lowest concentration of enzyme
(fumarase = 4.48 mg dm–3) and the average residence
time of 53 min, steady-state conversion of fumaric
acid was 55 %. At the same residence time and two
times higher concentration of enzyme (fumarase =
9.80 mg dm–3) steady–state conversion was 68 %.
Approximately the same steady-state conversion as
the conversion in the batch reactor11 (X 
 80 %),
was achieved with average residence time of
240 min. At this residence time, the experiment was
performed at two enzyme concentrations, but the
difference in steady-state conversion (Table 2) was
negligible. However, deactivation of enzyme was
not observed in the experiment during 50 hours and
the enzyme membrane reactor seemed to be a good
choice for continuous L-malic acid production cata-
lyzed by isolated fumarase.
The calculated values of volumetric productiv-
ity (QP), biocatalyst productivity (QBP) and bio-
catalyst consumption (BC) are shown in Table 2.
The highest volumetric productivity was achieved
at lower residence time for the fumarase concentra-
tion of 9.80 mg dm–3. With an enzyme concentra-
tion of 4.48 mg dm–3 and average residence time of
53 min biocatalyst productivity was the highest,
and the biocatalyst consumption (Table 2) the low-
est. In the case of L-malic acid production catalyzed
by isolated fumarase, the price of biocatalyst was
probably the decisive factor, because fumaric acid
is inexpensive and it is easily separated from the re-
action mixture.6,22 Thus, the biocatalyst productiv-
ity and biocatalyst consumption are very important
in this case.
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F i g . 2 – Production of L-malic acid by isolated fumarase
in the continuously operated EMR (0.1 mmol dm–3 phosphate
buffer pH 7; T = 30 °C; Vreactor = 10 cm
3; c0,fumaric acid =
63 mmol dm–3), (circles – experiment, line – model; grey –
fumaric acid, black – L-malic acid)
T a b l e 2 – Volumetric productivity21 (malic acid produced daily for the volume of reaction mixture), biocatalyst productivity21
(malic acid produced daily per amount of enzyme) and biocatalyst consumption (the amount of enzyme used for daily production of
one mmol of L-malic acid) at different conditions during the L-malic acid continuous production catalyzed by isolated fumarase
	/min fumarase/mg dm
–3 X/– QP/mmol dm
–3 d–1 QBP/mmol d
–1 mg–1 BC/mg mmol–1 d–1
53 4.48 0.55 943.67 210.74 0.005
53 9.80 0.68 1164.93 118.83 0.008
240.0 9.80 0.80 307.57 31.37 0.032
240.0 12.82 0.81 311.16 24.27 0.041
Continuous L-malic acid production catalyzed
by fumarase in permeabilized yeast cells
The permeabilization of yeast cells appears to
be very useful in the case of enzyme fumarase. The
activity of permeabilized cells in hydration of
fumaric acid was significantly higher than that of the
non-permeabilized ones.10,11 A mathematical model
for continuous production of L-malic acid was com-
posed of the kinetic equations (eqs. 5–6) and mass
balance equations (eqs. 9–10). Kinetic parameters of
this model were estimated earlier10,11 (Table 1) and
the model was confirmed in a continuous reactor
with cell retention. The results are shown in Fig. 3.
During the continuous L-malic acid production
by both yeasts, enzyme inactivation was observed,
but was not complete. It seems that the enzyme ac-
tivity became constant after 83 hours in the process
with the permeabilized cells of Saccharomyces
bayanus (Fig. 3A) and after 50 hours in the process
with permeabilized cells of baker’s yeast (Fig. 3B).
Decrease of enzyme activity was described by en-
zyme reverse inactivation scheme presented in
eq. 4. In addition, the model was upgraded by
eqs. 7-8, and these are the balance equations for the
active yeast and inactive yeast. Parameters of the
model (eqs. 7–8) were estimated from experimental
data, and are shown in Table 3.
Baker’s yeast cells have a higher inactivation
constant, as well as the activation constant than
S. bayanus cells. This is in accordance with the ex-
perimental results because the constant activity of
fumarase in Saccharomyces bayanus cells was
achieved around 30 hours later. Simulation of the
model gives more information on the activities of
enzymes in yeast cells (Fig. 4). It is obvious that al-
most 90 % of the initial enzyme activity in the cells
of baker’s yeast was lost, while in the cells of
Saccharomyces bayanus this loss was 96 %.
Regardless of the initial concentration of yeast,
the steady-state conversion was about 50 % in the
continuous L-malic acid production by both yeasts.
It could be seen from the data in Table 4
(Xfumaric acid, QP, QBP and BC) that both biocatalysts
were almost equally efficient in the continuous pro-
duction of L-malic acid. Baker’s yeast cells gave
somewhat higher volumetric productivity due to
higher concentration of fumaric acid in the feed. The
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F i g . 3 – Production of L-malic acid by permeabilized yeast
cells in the continuously operated reactor with cell retention
(0.1 mmol dm–3 phosphate buffer pH 7; T = 30 °C; Vreactor = 1 dm
3)
(A) Saccharomyces bayanus cells (c0,fumaric acid = 200 mmol dm
–3,
yeast = 36 g (wet weight) dm
–3;  = 887 min) (B) baker’s yeast
cells – Saccharomyces sp (c0,fumaric acid = 220 mmol dm
–3, yeast =
50 g (wet weight) dm–3;  = 914 min) (circles – experiment, line
– model; grey – fumaric acid, black – L-malic acid)
T a b l e 3 – Estimated inactivation and activation constants







–1 1.36·10–3 ± 5.95·10–5 2.38·10–3 ± 1.98·10–4
ka/min
–1 5.67·10–5 ± 3.34·10–6 2.40·10–4 ± 2.27·10–5
F i g . 4 – Decrease of enzyme activity in yeast cells – simu-
lated by model (black Saccharomyces bayanus cells, grey –
baker’s yeast cells – Saccharomyces sp)
low initial enzyme activity in baker’s yeast cells af-
fects lower biocatalyst productivity and higher bio-
catalyst consumption. Steady-state conversion of
fumaric acid and volumetric productivity are more
important than the amount of biocatalyst used, be-
cause the price of biocatalyst is very low when using
permeabilized yeast cells. Therefore, these bio-
catalysts are useful for the L-malic acid production.
Comparison of biocatalysts in the continuous
production of L-malic acid
The proposed mathematical models were vali-
dated in a continuous type reactor, which has enabled
the simulation of L-malic acid production in different
initial conditions. In order to compare the three
biocatalysts that have been used, the same initial
value for residence time ( = 900 min) and the
fumaric acid concentration in input flow (c0,fumaric acid =
250 mmol dm–3) were set. For each biocatalyst the
L-malic acid concentration in the steady state condi-
tions was calculated. Dependence of steady-state con-
version on biocatalyst concentrations is shown in Fig. 5.
Steady-state conversion of 70 % was chosen as
a reference because it was achieved in the industrial
production of L-malic acid by immobilized cells of
Brevibacterium flavum.6,23 Table 5 shows the
biocatalyst concentration, and calculated biocatalyst
productivity and biocatalyst consumption in
steady-state conversion of 70 %.
It can be concluded that the use of one mg of
purified fumarase in continuous production of
L-malic acids, corresponds to the use of enzyme in
68 g (wet weight) cells of S. bayanus or in 120 g
(wet weight) cells of baker’s yeast (Table 5). There-
fore, the use of purified enzyme in L-malic acid pro-
duction is uneconomical because whole cells are
cheaper. However, with the large quantities of cells
that are required, it is very difficult to handle in an
industrial reactor. For example, the same productiv-
ity as in industrial production in Japan (30 t/month
of L-malic acid in a 1000 dm3 reactor at a flow rate
of 450 dm3 h–1 of 1 mol dm–3 fumarate)6,23 in our case
could be achieved with a 5000 kg Saccharomyces
bayanus cells. This is because fumarase loses about
96 % of its initial activity in the cells due to enzyme
inactivation. Therefore, further studies are needed to
find a method to stabilize the enzymes in the cells.
Conclusion
Continuous production of L-malic acid cata-
lyzed by fumarase purified from porcine heart and
fumarase in cells of Saccharomyces bayanus or
baker’s yeast has been successfully performed.
High biocatalyst consumption, which was obtained
in the case of whole cell biocatalyst, is due to inac-
tivation of enzymes in the cells. Although yeast is a
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T a b l e 4 – Volumetric productivity, biocatalyst productivity
and biocatalyst consumption in the L-malic acid continuous






yeast/g (wet weight) dm
–3 36 50
Xfumaric acid/- 0.51 0.50
QP/mmol dm
–3 d–1 165.00 174.26
QBP/mmol g
–1 (wet weight) d–1 4.58 3.49
BC/g (wet weight) mmol–1 d–1 0.22 0.29
F i g . 5 – The dependence of steady-state conversion on ini-
tial biocatalyst concentration in the L-malic continuous pro-
duction at  = 900 min and c0,fumaric acid = 250 mmol dm
–3 – sim-
ulated by model (short dash line – isolated fumarase, solid line
– Saccharomyces bayanus cells, long dash line – baker’s yeast
cells – Saccharomyces sp)
T a b l e 5 – Biocatalyst concentration, biocatalyst productiv-
ity and biocatalyst consumption in the L-malic acid continuous
production at  = 900 min and c0,fumaric acid = 250 mmol dm
–3











g (wet weight) dm–3 180 315
QBP/
mmol mg–1 d–1 106.49
mmol g–1 (wet weight) d–1 1.56 0.89
BC/
mg mmol–1 d–1 0.0094
g (wet weight) mmol–1 d–1 0.64 1.12
very inexpensive biocatalyst, large quantities needed
for an interesting industrial production neutralize
the effectiveness of industrial applications.
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L i s t o f s y m b o l s
BC  biocatalyst consumption, mg mmol–1 d–1,
g (wet weight) mmol–1 d–1
c  molar concentration, mmol dm–3
ka  activation constant, min
–1
kd  inactivation constant, min
–1
Ki  inhibition constant, mmol dm
–3
Km  Michaelis-Menten constant, mmol dm
–3
QBP  biocatalyst productivity, mmol mg
–1 d–1,
mmol g–1 (wet weight) d–1
QP  volumetric productivity, mmol dm
–3 d–1
r  reaction rate, U cm–3
T  temperature, oC
t  time, min
V  volume, cm3, dm3
Vm  maximal reaction rate, U mg
–1, U g–1 (wet weight)
X  conversion, –
  mass concentration, g (wet weight) dm–3, mg dm–3
  average residence time, min
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